User profiles for Bethany Brunton
 | Bethany BruntonMayo Clinic Verified email at mayo.edu Cited by 688 |
Clinical activity of single-dose systemic oncolytic VSV virotherapy in patients with relapsed refractory T-cell lymphoma
Clinical success with intravenous (IV) oncolytic virotherapy (OV) has to-date been anecdotal.
We conducted a phase 1 clinical trial of systemic OV and investigated the mechanisms of …
We conducted a phase 1 clinical trial of systemic OV and investigated the mechanisms of …
[HTML][HTML] TIM-1 serves as a receptor for Ebola virus in vivo, enhancing viremia and pathogenesis
B Brunton, K Rogers, EK Phillips… - PLoS neglected …, 2019 - journals.plos.org
Background T cell immunoglobulin mucin domain-1 (TIM-1) is a phosphatidylserine (PS)
receptor, mediating filovirus entry into cells through interactions with PS on virions. TIM-1 …
receptor, mediating filovirus entry into cells through interactions with PS on virions. TIM-1 …
[HTML][HTML] IL-4/IL-13 polarization of macrophages enhances Ebola virus glycoprotein-dependent infection
KJ Rogers, B Brunton, L Mallinger… - PLoS neglected …, 2019 - journals.plos.org
Background Ebolavirus (EBOV) outbreaks, while sporadic, cause tremendous morbidity and
mortality. No therapeutics or vaccines are currently licensed; however, a vaccine has shown …
mortality. No therapeutics or vaccines are currently licensed; however, a vaccine has shown …
IMMUNO-COV v2. 0: Development and validation of a high-throughput clinical assay for measuring SARS-CoV-2-neutralizing antibody titers
Neutralizing antibodies are key determinants of protection from future infection, yet well-validated
high-throughput assays for measuring titers of SARS-CoV-2-neutralizing antibodies …
high-throughput assays for measuring titers of SARS-CoV-2-neutralizing antibodies …
Development and validation of IMMUNO-COV™: a high-throughput clinical assay for detecting antibodies that neutralize SARS-CoV-2
We here describe the development and validation of IMMUNO-COV™, a high-throughput
clinical test to quantitatively measure SARS-CoV-2-neutralizing antibodies, the specific subset …
clinical test to quantitatively measure SARS-CoV-2-neutralizing antibodies, the specific subset …
Frontline Science: CD40 signaling restricts RNA virus replication in Mϕs, leading to rapid innate immune control of acute virus infection
Many acute viral infections target tissue Mϕs, yet the mechanisms of Mϕ-mediated control
of viruses are poorly understood. Here, we report that CD40 expressed by peritoneal Mϕs …
of viruses are poorly understood. Here, we report that CD40 expressed by peritoneal Mϕs …
An unusual presentation of emphysematous cystitis
J Weddle, B Brunton, DR Rittenhouse - The American journal of emergency …, 1998 - Elsevier
Emphysematous cystitis is a rare disorder most commonly seen in women and associated
with urinary tract infections and poorly controlled diabetes mellitus. We report the case of a 76-…
with urinary tract infections and poorly controlled diabetes mellitus. We report the case of a 76-…
Clinical activity of systemic VSV-IFNβ-NIS oncolytic virotherapy in patients with relapsed refractory T-cell lymphoma.
2500 Background: Oncolytic virotherapy is a novel immunomodulatory therapeutic approach
for relapsed refractory hematologic malignancies. The Indiana strain of Vesicular Stomatitis …
for relapsed refractory hematologic malignancies. The Indiana strain of Vesicular Stomatitis …
[HTML][HTML] New transgenic NIS reporter rats for longitudinal tracking of fibrogenesis by high-resolution imaging
Fibrogenesis is the underlying mechanism of wound healing and repair. Animal models that
enable longitudinal monitoring of fibrogenesis are needed to improve traditional tissue …
enable longitudinal monitoring of fibrogenesis are needed to improve traditional tissue …
Abstract CT072: First in human (FIH) dose escalation studies of intravenous administration of VSV-IFNβ-NIS (Voyager-V1™) in Stage IV or recurrent endometrial …
…, MS Block, N Packiriswamy, BA Brunton… - Cancer Research, 2018 - AACR
Introduction. VSV-IFNβ-NIS is an oncolytic vesicular stomatitis virus (VSV; Rhabdovirus
family) with rapid replication kinetics and potent antitumor activity. VSV-IFNβ-NIS encodes the …
family) with rapid replication kinetics and potent antitumor activity. VSV-IFNβ-NIS encodes the …
